Research Analysts’ Weekly Ratings Changes for Sangamo Therapeutics (SGMO)
A number of firms have modified their ratings and price targets on shares of Sangamo Therapeutics (NASDAQ: SGMO) recently: 12/16/2024 – Sangamo Therapeutics was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating. 12/13/2024 – Sangamo Therapeutics was upgraded by analysts at Truist Financial Co. from a “hold” rating to a […]
More Stories
Morgan Stanley China A Share Fund, Inc. (NYSE:CAF) Short Interest Update
Morgan Stanley China A Share Fund, Inc. (NYSE:CAF – Get Free Report) was the target of a large increase in...
Short Interest in Ellington Credit (NYSE:EARN) Grows By 7.4%
Ellington Credit (NYSE:EARN – Get Free Report) saw a significant growth in short interest in November. As of November 30th,...
DocuSign, Inc. (NASDAQ:DOCU) Director Sells $50,516.40 in Stock
DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction...
HubSpot, Inc. (NYSE:HUBS) Short Interest Down 11.4% in November
HubSpot, Inc. (NYSE:HUBS – Get Free Report) was the recipient of a large decline in short interest in November. As...
Ares Commercial Real Estate (NYSE:ACRE) Rating Increased to Hold at StockNews.com
Ares Commercial Real Estate (NYSE:ACRE – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to...
TaskUs, Inc. (NASDAQ:TASK) COO Sells $1,133,158.57 in Stock
TaskUs, Inc. (NASDAQ:TASK – Get Free Report) COO Stephan Daoust sold 62,159 shares of TaskUs stock in a transaction on...